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Cyclophosphamide (Cy) is an alkylating agent which acts on actively dividing cells. 
It has been widely used as immunosuppressive drug in clinical  medicine  (1).  Cy has 
preferential toxicity for B cells compared to T  cells, but it is clear that T  cells also are 
affected  (2-4).  It has been reported  that Cy can also have immunoenhancing effects 
which are probably a result of the inactivation of suppressor T  cells or their precursors. 
Cy-sensitive suppressor  T  cells  have been  demonstrated  both  in  cell-mediated  and 
humoral  immune  responses  (5-10).  Other  T-cell  functions,  like  cytotoxic  T-cell 
responses  against  allogeneic  cells  as well  as  delayed  type hypersensitivity  reactions, 
are  relatively  resistant  to  Cy  (8,  10,  11).  There  is  now  increasing  evidence  that 
cytotoxic T  cells are also generated after exposure to major histocompatibility complex 
(MHC)-identical  cells expressing either viral antigens, chemically added haptens,  or 
minor histocompatibility  antigens  (12-15).  Efficient  lysis is obtained  only when  the 
cytotoxic T  cells and targets are syngeneic at the MHC. This kind of MHC-restricted 
cytotoxicity may play an important  role e.g.,  in the control of tumour development 
and  viral  diseases.  The cellular  basis  in  this  response  is  still  largely  unknown.  The 
experiments  reported  here show that  MHC-restricted  cytotoxic T-cell  responses  are 
more sensitive  to Cy than  allogeneic  responses.  Two types  of murine  MHC  (H-2)- 
restricted cytotoxic responses were used: the in vitro primary response to trinitrophenyl 
(TNP)-coupled syngeneic cells  (13,  16)  and the in vitro cytotoxic response of female 
cells to male spleen cells (H-Y antigen), in which response in vivo priming is required 
(14). 
Materials  and Methods 
Animals and Immunizations.  C57BL/6 and CBA mice were obtained from the breeding unit 
of this department.  C57BL/6 female mice were primed to the male-specific antigen  (H-Y) by 
the intraperitoneal injection of 1 ×  107 viable syngeneic male spleen cells 3 wk before use. 
Administration of Cyclophosphamide.  Cyclophosphamide (Syklofosfamid, L~ike O.Y., Turku, 
Finland)  was  dissolved  in  sterile  water  immediately  before  use  and  graded  amounts  were 
injected intraperitoneally 2 d before starting the in vitro spleen cell cultivation. 
In  Vitro Sensitizations and Cytotoxic Assay.  The method used to elicit  and assay a cytotoxic T- 
cell response has been previously described (17). Briefly,  spleens  from female mice (unprimed 
or primed to the H-Y antigen) were removed and teased, and the resulting cell suspension was 
washed once in RPMI medium and then resuspended at 5  ×  10  n ceUs/ml in RPMI medium 
containing 10% fetal calf serum (FCS)  (Gibco, Glasgow, Scotland) with  10 mM N-2-hydroxy- 
ethylpiperazine-N'-ethane sulfonic acid  (Hepes),  glutamine,  antibiotics,  and  5  X  10  -s M  2- 
mercaptoethanol. The responding Cells were cocultured with an equal number of Mitomycin- 
C treated stimulator cells in 25-cm  2 plastic tissue culture flasks. The stimulator cells were either 
allogeneic, syngeneic male, or TNP-modified. TNP-modification was done according to Shearer 
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TAnLE  I 
Effect  of In  Viva Cy Pretreatment on In  Vitro Cytotoxic Responses to Allogeneic Cells,  TNP-Modified 
Syngeneic Spleen Cells or to Syngeneic Male Spleen Cells 
Donor of responder  Dose of  In vitro stimulators  Target:~  Corrected '7,, 
spleen cells  Cy*  lysis (SE)§ 
C57BL/6 
C57BL/6 
C57BL/6 <2 (primed 3 
wk previously with 
male cells 
mg/kg 
0  CBA  CBA  37.9 (2.8) 
20  CBA  CBA  40.1 (2.9) 
100  CBA  CBA  37.0 (1.9) 
200  CBA  CBA  35.5 (1.4) 
0  C57BL/6-TNP  C57BL/6-TNP  35.4 (4.8) 
20  C57BL/6-TNP  C57BL/6-TNP  17.6 (2.7) 
100  C57BL/6-TNP  C57BL/6-TNP  10.5 (2.0) 
200  C57BL/6-TNP  C57BL/6-TNP  -3.2 (0.2) 
0  C57BL/6 ~  C57BL/6 ~  42.4 (4.1) 
C57BL/6 <2  -0.3 (0.6) 
20  C57BL/6 d  C57BL/6 ~  25.6 (1.6) 
C57BL/6 <2  -2.1  (0.2) 
100  C57BL/6 d~  C57BL/6 d~  0.0 (1.0) 
C57BL/6 <2  -2.1 (1.0) 
200  C57BL/6 d  C57BL/6 c~  -  1.5 (0.1) 
C57BL/6 <2  -2.8 (2.3) 
* Cy was injected intraperitoneally 2 d before starting the in vitro culture. 
:]: 51Cr-labeled, concanavalin A-induced lymphoblasts. 
§ Attacker: target  ffi  lO:l. 
(16). After 5 d of incubation in a humidified, 10% CO2 atmosphere, the cultures were harvested, 
washed once in  RPMI  medium,  and  then  resuspended  in Eagle's minimal essential  medium 
with  10%  FCS and  10  mM  Hepes.  The cell concentration  was adjusted  and  three doubling 
dilutions made. The various concentrations of attacking cells were then plated in triplicate in 
wells of microtiter plate  and  2-4  ×  104  SlCr-labeled  target  cells were added  per  well.  The 
target  cells were spleen  cells which  had  been  cultured  48-72  h  in  the  presence  of 4  p,g/ml 
concanavalin A, labeled for 90 rain with atCr-sodium chromate and then washed twice. In anti- 
TNP  cytotoxic  responses  the  targets  were  TNP-modified  after  5tCr-labeling.  The  attacker: 
target cell ratios normally used were  16:1, 8:1, 4:1, and 2:1. The plates were spun briefly and 
then incubated at 37°C in a  10% CO2 atmosphere for 3 h  before harvesting the supernates  for 
gamma counting. Maximum-release was the amount ofatCr released from Triton-treated target 
cells (Rohm  & Haas Co., Philadelphia,  Pa.);  spontaneous  release was that  released by target 
cells incubated  in medium alone. The corrected percent lysis was computed according to the 
formula ofWunderlich et al. (18). Regression lines were calculated from the percent of corrected 
lysis at  the four attacker:target  cell ratios used, and  from these lines the percent  of corrected 
lysis at  I0:1  attacker:target  was  taken.  Only  when  the r  2 value for such  regression  lines  lay 
between  0.9  and  1.0  was  the  percent  of corrected  lysis  at  10:1  regarded  as  positive.  Each 
experiment reported in the table was repeated at least three times and concordant results were 
obtained. The values given are from representative experiments. 
Results 
The data depicted in Table I show that spleen cells from C57/BL/6 (H-2  b) mice 
responded in  vitro to allogeneic stimulator cells  (CBA,  H-2  k)  regardless  of the Cy 
pretreatment of the responder cell donor. But Cy pretreatment had a clear effect on 
the  cytotoxic response  of C57BL/6  mice  to  TNP-coupled  syngeneic  spleen  cells. 
Already with the lowest dose tested  (20 mg/kg)  a  clear decrease in cytotoxicity was 
noticed.  The  anti-H-Y  cytotoxic  response  was  similarly  sensitive  to  Cy.  In  this 292  M.  HURME  BRIEF  DEFINITIVE REPORT 
experiment the responder female mice were primed in vivo with syngeneic male cells 
and Cy was given 2 d before in vitro restimulation with male cells. 
Discussion 
The present studies examined the effect of Cy on two types of T-cell cytotoxicity, 
namely the allogeneic response and the H-2-restricted cytotoxic responses. The former 
was shown  to be relatively resistant  whereas H-2-restricted cytotoxicity was readily 
depressed with a  low dose of Cy. 
It  is  unclear  whether  the  differential  effect  of Cy  on  these  (and  other)  T-cell 
functions is due to a selective depletion of some T-cell subpopulations (e.g. cytotoxic 
T-cell precursors and/or helper cells for H-2-restricted responses) or to an alteration 
of function in a given T-cell population. The former alternative may be supported by 
the  studies  with  Ly antigen  markers:  the  generation  of cytotoxic T  cells  to  TNP- 
modified syngeneic cells required the presence of Ly 1  +2+3 + cells, whereas alloreactive 
prekiller  activity  mainly  resided  in  the  Ly  1-2+3 +  subclass  (19).  Ly  1+2+3  +  cells 
comprise 250% of peripheral T  cells. They are immature and appear first in ontogeny 
and  are  sensitive  to  adult  thymectomy  (19).  Therefore,  some  of  these  cells,  e.g. 
precursor cells for some suppressor T  cells and for H-2-restricted cytotoxic cells, might 
be rapidly dividing and thus, sensitive to Cy. 
One explanation for the differential Cy sensitivities of allogeneic and H-2 restricted 
cytotoxic  responses  may  be  that  there  are  lower  numbers  of precursors  for  H-2 
restricted  responses and Cy simply inhibits  the clone expansion.  Fischer  et  al.  (20) 
have demonstrated  that  the frequency of cytotoxic cell precursors reactive to TNP- 
modified syngeneic cells are one-half of the frequency of alloreactive precursors and 
it was also noticed  that  one precursor cell undergoes  three  to four cell divisions to 
produce at  least 8-16 cytotoxic lymphocytes after antigenic  stimulation.  Thus,  the 
difference in cell proliferation in anti-TNP and in allogeneic responses is small and 
speaks against the possibility mentioned above. 
In anti-H-Y cytotoxic response Cy has its effect on primed cells,  inhibiting  their 
response to restimulation.  This  indicates  that  not  only the  precursor cells  but  also 
memory cells in H-2 restricted responses are Cy sensitive. 
Horton et al. x have recently demonstrated that anti-Ly-6 antiserum reveals heter- 
ogeneity among the precursors of cytotoxic T  cells in a similar way as Cy: allogeneic 
precursors are  Ly 6-,  whereas  the  generation  of cytotoxic cells  to  hapten-modified 
syngeneic cells is partially abrogated by serum pretreatment. The effector cells in both 
type of responses were Ly 6 +. 
Differential sensitivity of these two types ofT-cell cytotoxicity to Cy (maybe also to 
other immunosuppressive drugs?) may have some clinical implications: in some cases 
suppression of MHC restricted  responses might  be desirable  (autoimmune diseases) 
but  in  transplant  recipients,  the  drug-induced  decrease  in  allograft  response  can 
totally abolish  the  MHC-restricted  response  and  this  may result  in  the  increase of 
virus infections and virus--induced tumours. 
Summary 
Spleen cells from cyclophosphamide-treated mice responded in vitro to aUogeneic 
stimulator cells but  not  to TNP-coupled syngeneic spleen cells. Similarly, cells from 
J M. A, Horton, P. C. L. Beverly,  and E. Simpson. Expression of Ly-6 alloantigen during differentiation 
of cytotoxic T cells. Manuscript submitted for publication. M.  HURME  BRIEF DEFINITIVE REPORT  293 
female mice, primed in vivo with syngeneic male cells, could not respond in vitro to 
male  spleen  cell  stimulation  if the  mice  were  pretreated  with  cyclophosphamide. 
These  results  suggest  that  the  precursor cells  for H-2-restricted  cytotoxic responses 
belong  to  a  different  T-cell  subpopulation  than  the  precursor  cells  for  allogeneic 
responses. 
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